Clinical use of [TIMP-2]center dot[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel Article

Open Access Industry Collaboration International Collaboration

cited authors

  • Guzzi, Louis M.; Bergler, Tobias; Binnall, Brian; Engelman, Daniel T.; Forni, Lui; Germain, Michael J.; Gluck, Eric; Goecze, Ivan; Joannidis, Michael; Koyner, Jay L.; Reddy, V. Seenu; Rimmele, Thomas; Ronco, Claudio; Textoris, Julien; Zarbock, Alexander; Kellum, John A.

Publication Date

  • June 20, 2019

webpage

published in

category

keywords

  • Acute kidney injury
  • Biomarker technology
  • Biomarker testing
  • Clinical guidelines
  • Critical care
  • Diagnosis
  • Expert panel
  • Insulin-like growth factor binding protein 7
  • Protocols
  • Tissue inhibitor of metalloproteinases-2

volume

  • 23